Avidity Partners Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-282,752	Closed	-$8.34M	–	91
2023 Q2	$8.34M	Buy	+282,752	New	+$8.34M	0.29%	76
2021 Q3	–	Sell	-86,100	Closed	-$6.75M	–	112
2021 Q2	$6.75M	Buy	+86,100	New	+$6.75M	0.18%	84